Biomedical inorganic chemistry offers the potential for the design novel therapeutic agents for the treatment of diseases, which are currently intractable. Therapeutic metalodrugs have since long been employed to restore human physiology. Vanadium and chromium presents an outstanding case of a transition elements, the omnipotent physicochemical properties of which have unearthed it_s potential use as a serious insulin mimtic agents, well suited in the treatment of the heterogeneous disease of diabetes mellitus types I and II. The design of such metallodrugs has been at the fore front of the research depending on analogy of the previous work, simple structure, bioavailability, solubility and absorption property. Four different analog ligands have been synthesized to coordinate with VO (II) and Cr (III) metal ions to produce eight different complexes. Six different amino acids have chosen to coordinate with VO (II) and Cr (III) metal ions to produce twelve different complexes. Marcapto acetic acid and mandelic acid are also chosen to coordinate with VO (II) and Cr (III) metal ions to produce four different complexes. Five different sugars have been chosen to coordinate with VO (II) and Cr (III) metal ions to produce ten different complexes. Several of the synthesized compounds were isolated and characterized by studying their physicochemical properties such as C.H.N.S and metal analysis, vibrational and electric spsectra, conductivity, magnetic properties, in addition to 1H.N.M.R spectral study for some complexes. The formation of some of the complexes were studied in solution following the mole ratio method. The results of both solid state and solution studies gave identical results.